Prefilled Syringes Market Analysis

Prefilled Syringes Market Analysis

The glass-based prefilled syringes market accounted for USD 4.1 billion in 2020. Currently, most prefilled syringes are made of glass. This is due to the fact that most of the glass prefilled syringes allow delivery of highly viscous medications. Furthermore, glass prefilled syringes can be utilized across a wide range of therapeutic areas, such as blood stimulants, vaccines, and therapeutic proteins while increasing product life span that will positively impact the segment growth.

The single-chamber design segment in the prefilled syringes market exceeded USD 4.6 billion in 2020 an account of advantages pertaining to single-chamber prefilled syringes over vials such as precise dosing and safety. Moreover, simple storage and ease of usage associated with single chamber design will increase its preference over the forecast period, thus also proving beneficial for the overall industry expansion.

To get key market trends

  Download Free Sample

The diabetes segment held 34% of the prefilled syringes market share in 2020. Diabetes requires constant medications for treatment. Rising prevalence of diabetes coupled with favourable demographic trends also increases demand for prefilled syringes with insulin that will prove beneficial for segment revenue.

North America prefilled syringes market is predicted to showcase around 12% growth rate till 2027 owing to the rising geriatric population base susceptible to chronic diseases in the U.S. and China. High acceptance of patient safety measures along with rapid adoption of prefilled syringes in this region will further enhance the market expansion. The market will also prosper due to the presence of major industry players with strong distribution network that are associated with prefilled syringes business.